Wayfinding Financial LLC Makes New $371,000 Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Wayfinding Financial LLC bought a new stake in UnitedHealth Group Incorporated (NYSE:UNH) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 734 shares of the healthcare conglomerate’s stock, valued at approximately $371,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in UNH. One Charles Private Wealth Services LLC raised its holdings in shares of UnitedHealth Group by 4.4% in the 4th quarter. One Charles Private Wealth Services LLC now owns 618 shares of the healthcare conglomerate’s stock valued at $313,000 after buying an additional 26 shares during the period. Gutierrez Wealth Advisory LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at $230,000. Antonelli Financial Advisors LLC purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at $754,000. Semanteon Capital Management LP raised its holdings in shares of UnitedHealth Group by 419.5% in the 4th quarter. Semanteon Capital Management LP now owns 2,452 shares of the healthcare conglomerate’s stock valued at $1,240,000 after buying an additional 1,980 shares during the period. Finally, Lowe Brockenbrough & Co. Inc. increased its holdings in UnitedHealth Group by 0.8% during the 4th quarter. Lowe Brockenbrough & Co. Inc. now owns 23,193 shares of the healthcare conglomerate’s stock worth $11,732,000 after purchasing an additional 195 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the company. Barclays cut their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a report on Friday, January 17th. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a research report on Friday, January 10th. Stephens upped their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Finally, Oppenheimer upped their target price on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Twenty analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $629.32.

Insider Activity

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $512.30 on Friday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The company has a market cap of $468.61 billion, a price-to-earnings ratio of 33.05, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The stock has a 50 day simple moving average of $510.24 and a 200-day simple moving average of $547.97. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period last year, the business posted $5.83 EPS. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.64%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.